2-178324216-G-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032523.4(OSBPL6):c.142G>A(p.Glu48Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000532 in 1,582,500 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E48Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_032523.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152068Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000281 AC: 63AN: 223930 AF XY: 0.000208 show subpopulations
GnomAD4 exome AF: 0.000562 AC: 804AN: 1430314Hom.: 2 Cov.: 30 AF XY: 0.000503 AC XY: 356AN XY: 708316 show subpopulations
GnomAD4 genome AF: 0.000250 AC: 38AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74398 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.142G>A (p.E48K) alteration is located in exon 4 (coding exon 2) of the OSBPL6 gene. This alteration results from a G to A substitution at nucleotide position 142, causing the glutamic acid (E) at amino acid position 48 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at